tiprankstipranks
Crispr Therapeutics (CRSP)
:CRSP
US Market

Crispr Therapeutics AG (CRSP) Technical Analysis

Compare
9,016 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Crispr Therapeutics’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 2.07, suggesting Crispr Therapeutics is a Sell.
Crispr Therapeutics’s (CRSP) 20-Day exponential moving average is 44.73, while Crispr Therapeutics’s (CRSP) share price is $50.43, making it a Buy.
Crispr Therapeutics’s (CRSP) 50-Day exponential moving average is 44.06, while Crispr Therapeutics’s (CRSP) share price is $50.43, making it a Buy.

Crispr Therapeutics AG (CRSP) Pivot Points

Feb 21, 2025, 02:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
47.89
50.06
51.54
53.71
55.19
57.36
58.84
Fibonacci
50.06
51.45
52.32
53.71
55.10
55.97
57.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Feb 21, 2025, 02:27 PM
Period
Simple
Exponential
MA5
49.78Buy
49.52Buy
MA10
45.15Buy
46.95Buy
MA20
43.52Buy
44.73Buy
MA50
42.81Buy
44.06Buy
MA100
45.64Buy
45.81Buy
MA200
49.49Buy
50.72Sell
Crispr Therapeutics’s (CRSP) 10-Day exponential moving average is 46.95, while Crispr Therapeutics’s (CRSP) share price is $50.43, making it a Buy.
Crispr Therapeutics’s (CRSP) 100-Day exponential moving average is 45.81, while Crispr Therapeutics’s (CRSP) share price is $50.43, making it a Buy.
Crispr Therapeutics’s (CRSP) stock price is $50.43 and Crispr Therapeutics’s (CRSP) 50-day simple moving average is 42.81, creating a Buy signal.
Crispr Therapeutics’s (CRSP) stock price is $50.43 and Crispr Therapeutics’s (CRSP) 100-day simple moving average is 45.64, creating a Buy signal.
Crispr Therapeutics’s (CRSP) stock price is $50.43 and Crispr Therapeutics’s (CRSP) 200-day simple moving average is 49.49, creating a Buy signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Feb 21, 2025, 02:27 PM
Name
Value
Implied Action
RSI (14)
65.76
Neutral
STOCH (9,6)
78.23
Neutral
STOCHRSI (14)
78.23
Neutral
MACD (12,26)
2.07
Sell
ADX (14)
22.52
Neutral
Williams %R
-30.97
Buy
CCI (14)
146.73
Sell
ATR (14)
2.98
-
Ultimate Oscillator
53.24
Neutral
ROC
19.96
Buy
Crispr Therapeutics’s (CRSP) Relative Strength Index (RSI) is 65.76, creating a Neutral signal.
Crispr Therapeutics’s (CRSP) Trend Strength Indicator (ADX) is 22.52, creating a Neutral signal.
Crispr Therapeutics’s (CRSP) Commodity Channel Index (CCI) is 146.73, creating a Sell signal.
Crispr Therapeutics’s (CRSP) Price Rate of Change (ROC) is 19.96, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 65.76, which suggests CRSP is a Neutral.
      What is CRSP’s MACD?
      CRSP’s MACD is 2.07, which suggests CRSP is a Sell.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 49.78, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 43.52, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 42.81, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 49.49, which suggests CRSP is a Buy.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -30.97, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 146.73, which suggests CRSP is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis